Avita Medical Ltd - Asset Resilience Ratio
Avita Medical Ltd (RCEL) has an Asset Resilience Ratio of 14.08% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2025)
This chart shows how Avita Medical Ltd's Asset Resilience Ratio has changed over time. Check Avita Medical Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Avita Medical Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Avita Medical Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $7.94 Million | 14.08% |
| Total Liquid Assets | $7.94 Million | 14.08% |
Asset Resilience Insights
- Moderate Liquidity: Avita Medical Ltd has 14.08% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Avita Medical Ltd Industry Peers by Asset Resilience Ratio
Compare Avita Medical Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Vieworks Co. Ltd
KQ:100120 |
Medical Devices | 7.81% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Respiri Ltd
AU:RSH |
Medical Devices | 0.46% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
|
Implanet SA
PA:ALIMP |
Medical Devices | 0.55% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
Annual Asset Resilience Ratio for Avita Medical Ltd (1999–2025)
The table below shows the annual Asset Resilience Ratio data for Avita Medical Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 14.08% | $7.94 Million | $56.39 Million | -13.31pp |
| 2024-12-31 | 27.39% | $21.84 Million | $79.71 Million | -32.57pp |
| 2023-12-31 | 59.96% | $66.94 Million | $111.64 Million | -2.30pp |
| 2022-12-31 | 62.26% | $61.18 Million | $98.26 Million | +36.70pp |
| 2021-12-31 | 25.56% | $29.65 Million | $116.02 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $82.46 Million | -- |
| 2019-12-31 | 0.00% | $0.00 | $25.78 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $23.00 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $7.67 Million | -- |
| 2015-12-31 | 6.24% | $537.05K | $8.60 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $5.44 Million | -- |
| 2010-12-31 | 0.36% | $67.33K | $18.69 Million | -1.80pp |
| 2009-12-31 | 2.16% | $169.97K | $7.86 Million | -1.91pp |
| 2008-12-31 | 4.07% | $322.82K | $7.93 Million | +1.60pp |
| 2007-12-31 | 2.47% | $382.70K | $15.51 Million | -10.72pp |
| 2001-12-31 | 13.19% | $667.06K | $5.06 Million | -10.50pp |
| 2000-12-31 | 23.69% | $1.28 Million | $5.42 Million | -2.46pp |
| 1999-12-31 | 26.14% | $733.43K | $2.81 Million | -- |
About Avita Medical Ltd
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more